Michael Platt
Michael Platt

Profile Details

Login Credentials

Contact Name:
Michael Platt
Brief Bio:
Michael has over 24 years of industry experience and a broad knowledge of the pharmaceutical, biotechnological, medical device, and healthcare fields. His expertise spans prelaunch, launch, and postlaunch initiatives including publication planning, advisory boards, sales training, MSL training, digital engagement, and regulatory writing. In addition, Michael worked for 10+ years in continuing education where he issued credentials and certifications to physicians, nurses, and pharmacists, as well as publication professionals. Some of his therapeutic areas of focus include biologics, oncology, hematology, rare diseases, cardiology, allergy and asthma, infectious disease, gastroenterology, urology, and rheumatology.

Michael manages a team of professionals who develop compelling, yet compliant, medical communications. The team at Virgo Health focuses on strategic consulting for medical affairs and scientific communication initiatives. Other offerings from Virgo Health include advisory board and steering committee meetings with medical information and clinical advisors, thought leader identification and development, market surveillance, and full-scale publication planning.

Michael currently provides strategic consulting for peer-to-peer initiatives on the cardio-protective benefits of Jardiance in patients with type 2 diabetes who have had a previous cardiovascular event. Michael also worked on the Door-to-Needle initiative funded by Genentech, as well as the Genentech product Retavase. To bring attention to the finding that earlier treatment for MI improved outcomes for patients, his team developed a program that, when implemented, reduced treatment times for suspected heart attack victims, which improved patient outcomes.

Another physician-based program that immediately improved patient outcomes addressed a rare disease, infantile spasms or West syndrome, and was supported by Questcor. Many pediatric neurologists were treating the symptoms of this cognitively detrimental disease, but they were not completing a second test to insure that the resulting hypsarrhythmia was resolved in the infant. Michael¿s team developed a series of educational programs that increased awareness and action on the part of these physicians.

Michael came to Virgo Health from MedVal, where as President, EVP, he led a writing and editorial team focused on publication planning and publications, as well as regulatory writing and medical affairs initiatives. Previously, he was CEO of Fission Communications, a New York-based medical education and communications company he founded in 2001, where he guided the development and execution of distinctive medical communications programs. He was also Director of Business Development at Ventiv Health Communications in Stamford, Connecticut, and has held positions at Genecom, LLC, and Q.E.D. International, Inc. Michael began his career in the research sector of the pharmaceutical industry as a project technician at OSI Pharmaceuticals, a drug discovery company based in New York.

Michael is the past chair of the CMPP Board, the certification body of the International Society of Medical Publication Professionals (ISMPP). He is also an active member of the ISMPP U Committee. As a past chair of ISMPP U, Michael assisted in establishing needs-based sessions for ISMPP U that met educational gaps for publication professionals.

Contact Information

First Name:
Last Name:
Managing Director
Virgo Health

Professional Details

Professional Degrees:

Company Details

Type of Company:
Communications Agency

CMPP Information

CMPP Directory Opt In:
Date Certified:
Certification Expiry:

Other Information

Annual Meeting Faculty:
11th Annual Meeting Faculty, 14th Annual Meeting Faculty, 15th Annual Meeting Faculty
ISMPP West Faculty:
2018 Faculty, 2019 Faculty